SCHEMBL8767774

SCHEMBL8767774

C[C@]12C[C@H](c3ccc(-c4cccnc4)cc3)[C@H]3[C@@H](CC[C@@]4(O)CC5(CC[C@H]34)OCCO5)[C@H]1CC[C@]2(O)CCCOC1CCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8768102 0.88 STS (0.33) —
SCHEMBL8769017 0.87 MEN1 (0.33) —
SCHEMBL9176180 0.87 MEN1 (0.33) —
SCHEMBL8768790 0.86 MEN1 (0.35) —
SCHEMBL8768158 0.83 MEN1 (0.30) —
SCHEMBL8768966 0.83 MEN1 (0.33) —
SCHEMBL9164654 0.76 — —
SCHEMBL9471536 0.76 PGR (0.38) —
SCHEMBL13417509 0.74 PGR (0.35) —
SCHEMBL9469845 0.68 PGR (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567469-B1 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES SCHERING AG (DE) 1997-08-27 — — EP disclosed
US-5426102-A Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties SCHERING AKTIENGESELLSCHAFT (DE) 1995-06-20 — — US disclosed
Send feedback